The previously reported detection of vascular endothelial growth factor/HIF-1α double-positive CTC [19] in the blood of breast cancer patients suggests that these cells have responded to prior hypoxic conditions in the tumor tissue and may experience a pulse of reoxygenation after release into the blood circuit [20], as simulated in our present in vitro model. The gene discussed is HIF1A; the disease is breast cancer.